In a rodent exercise model, MOTS-c-treated animals ran about 26% farther than untreated controls, suggesting the peptide may support physical performance at the preclinical level (Lee et al., Cell Metabolism, 2015).
Bar fill is proportional to relative running endurance; rodent exercise model, Lee et al. 2015.









